Answers are grounded in this paper and cite their sources.
Clascoterone cream 1% is a topical androgen receptor inhibitor approved to treat acne vulgaris in patients =>12 years of age. This report provides details of patients who developed laboratory signs of hypothalamic-pituitary-adrenal (HPA) axis suppression without clinical signs of adrenal suppression during the clascoterone development program.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: